
About Ikesia Biologics Private Limited
Data last updated:
Ikesia Biologics Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 10 June 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2022PTC162282.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sawraj Singh and Rekha Nagpal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lab Unit No. Mepl03 Bangalore Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.4 Lakh. For the same year it recorded a net profit of ₹2.14 Lakh (net margin 7.8%) and EBITDA of ₹7.2 Lakh (EBITDA margin 26.3%).
The company is associated with 1 brand: Ikesia biologics. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ikesiabiologics.com.
Company details
CIN history
Ikesia Biologics has one previous CIN (Corporate Identification Number): U73100KA2022OPC162282. The current CIN is U73100KA2022PTC162282, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100KA2022PTC162282 | Current |
| U73100KA2022OPC162282 | Previous |
Contact details
Ikesia Biologics Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressLab Unit No. Mepl03 Bangalore Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ikesia Biologics operates one associated brand: Ikesia biologics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers biologics characterization, fermentation upscaling, and downstream services. | ikesiabiologics.com |
Business activity
The main business activity of Ikesia Biologics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Ikesia Biologics Private Limited, buy the company report.
Financials of Ikesia Biologics Private Limited
FY 2025 filings availableIkesia Biologics Private Limited reported revenue of ₹27.4 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹7.2 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹2.14 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 26.3% | |
| Net Profit Margin | 7.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ikesia Biologics Private Limited, buy the company report.
Board of directors of Ikesia Biologics Private Limited
Ikesia Biologics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sawraj Singh | Director | 10 Jun 2022 | 4 Years 5 Months | Current |
| Rekha Nagpal | Director | 19 Oct 2022 | 4 Years 0 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2023 | 100853353 | Others | ₹6 Lakh | Satisfied | |
| 22 Dec 2023 | 100853351 | Others | ₹44 Lakh | Satisfied |
To see the full charge records of Ikesia Biologics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Ikesia Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ikesia Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ikesia Biologics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ikesia Biologics Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rekha Nagpal was appointed as Director on 19 Oct 2022.
Frequently asked questions
Ikesia Biologics is an active private limited company based in Bangalore, Karnataka, India. The company works in science research, within the research and development industry. It was incorporated on 10 June 2022 (4+ years old) and is registered under CIN U73100KA2022PTC162282.
Ikesia Biologics has 2 current directors:
- Sawraj Singh - Director
- Rekha Nagpal - Director
The latest financial statements of Ikesia Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Ikesia Biologics is U73100KA2022PTC162282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ikesia Biologics was incorporated on 10 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
Rekha Nagpal was appointed as Director on 19 Oct 2022. Sawraj Singh was appointed as Director on 10 Jun 2022.
Ikesia Biologics can be reached through the website ikesiabiologics.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Ikesia Biologics is at Lab Unit No. Mepl03 Bangalore Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100.
Ikesia Biologics operates in the research and development industry, in the science research segment.
Ikesia Biologics has open charges of ₹50 Lakh and satisfied charges of ₹50 Lakh as per latest MCA filings.

